in August of 2021. Dash pharmaceuticals put our testosterone generic on the market.
That means that they have had 1 year and 4 months on the market.
I am wondering whether they have sold any by now. With an addressable market segment of around $20million and with quite a few competitors already in place, it was never going to be huge $ for us.
Has anybody seen a revenue update for this product. And what is projected to happen?
Ann: Launch of prilocaine and lidocaine cream in United States, page-21
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
